Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Kisinovsky · SciRah

Researcher profile · Semantic Scholar

I. Kisinovsky

Share profile

I. Kisinovsky — researcher profile on SciRah

h-index: 9
Works: 25
Citations: 486

Most-cited papers

Enzyme replacement therapy with velaglucerase alfa in Gaucher disease: Results from a randomized, double‐blind, multinational, Phase 3 study
D. González, H. Ben Turkia, E. Lukina, I. Kisinovsky +7 more
2013American journal of hematology/oncology81 citations Open access
Semantic Scholar
Misdiagnosis in Fabry disease.
C. Marchesoni, Norma Roa, A. Pardal, Pablo Neumann +6 more
2010Jornal de Pediatria80 citations
Semantic Scholar
Velaglucerase alfa enzyme replacement therapy compared with imiglucerase in patients with Gaucher disease
H. Ben Turkia, D. González, N. Barton, A. Zimran +13 more
2013American journal of hematology/oncology68 citations Open access
Semantic Scholar
Brain MRI findings in patients with Fabry disease.
R. Reisin, C. Romero, C. Marchesoni, Gabriella Napoli +3 more
2011Journal of Neurological Sciences66 citations
Semantic Scholar
Two‐Dimensional Speckle Tracking Echocardiography for Early Detection of Myocardial Damage in Young Patients with Fabry Disease
M. C. Saccheri, T. Cianciulli, J. Lax, J. Gagliardi +5 more
2013Echocardiography55 citations Open access
Semantic Scholar
Velaglucerase alfa (VPRIV) enzyme replacement therapy in patients with Gaucher disease: Long-term data from phase III clinical trials
D. Hughes, D. González, E. Lukina, A. Mehta +9 more
2015American journal of hematology/oncology52 citations Open access
Semantic Scholar
Proinflammatory and proosteoclastogenic potential of peripheral blood mononuclear cells from Gaucher patients: Implication for bone pathology.
J. Mucci, M. F. Cuello, I. Kisinovsky, M. Larroudé +2 more
2015Blood Cells, Molecules & Diseases30 citations Open access
Semantic Scholar
Neuro-Otological and Peripheral Nerve Involvement in Fabry Disease
S. Carmona, R. Weinschelbaum, A. Pardal, C. Marchesoni +6 more
2017Audiology Research13 citations Open access
Semantic Scholar
Home infusion program for Fabry disease: experience with agalsidase alfa in Argentina.
I. Kisinovsky, G. Cáceres, Cristina Coronel, R. Reisin
2013Medicina12 citations
Semantic Scholar
Apical Left Ventricular Hypertrophy and Mid‐Ventricular Obstruction in Fabry Disease
T. Cianciulli, M. C. Saccheri, Segundo Fernández, C. Fernández +2 more
2015Echocardiography8 citations Open access
Semantic Scholar
[Guidelines for diagnosis, monitoring and treatment of Fabry disease].
Pablo Neumann, N. Antongiovanni, A. Fainboim, I. Kisinovsky +23 more
2013Medicina7 citations
Semantic Scholar
The Continuous Challenge of Diagnosing patients with Fabry disease in Argentina Genotype, Experiences, Anecdotes, and New Learnings
P. Rozenfeld, R. Ceci, Norma Roa, I. Kisinovsky
20155 citations Open access
Semantic Scholar
Major cardiovascular adverse events in Fabry disease patients receiving agalsidase alfa.
G. Ferrari, R. Reisin, I. Kisinovsky, Pablo Neumann +6 more
2021Medicina3 citations
Semantic Scholar
157. Enzyme replacement therapy with velaglucerase alfa significantly improves key clinical parameters in type 1 Gaucher disease: Positive results from a randomized, double-blind, global, phase III study
A. Zimran, D. González, E. Lukina, M. Ben Dridi +3 more
20103 citations
Semantic Scholar
Agalsidase alfa long-term effect on left ventricular hypertrophy in Fabry disease.
G. Ferrari, I. Kisinovsky, R. Reisin, Paula Rozenfeld +4 more
2024Medicina2 citations
Semantic Scholar
Looking for predictors of mortality in patients with Fabry disease on enzyme replacement therapy
R. Reisin, G. Ferrari, I. Kisinovsky, Pablo Neumann +11 more
20162 citations
Semantic Scholar
Effect of COVID19 pandemic on Argentinian Fabry and Gaucher patients
P. Rozenfeld, I. Kisinovsky
2022Molecular Genetics and Metabolism0 citations Open access
Semantic Scholar
Cardiovascular mortality and potential predictors in patients with Fabry disease treated with agalsidase alfa
Verónica Finn, G. Ferrari, R. Reisin, Pablo Neumann +6 more
20170 citations
Semantic Scholar
Osteoclastogenesis functional study of osteoclasts precursors from Gaucher disease patients
P. Rozenfeld, J. Mucci, F. Cuello, I. Kisinovsky +2 more
20140 citations
Semantic Scholar
Corrigendum
H. Ben Turkia, D. González, N. Barton, A. Zimran +13 more
20130 citations
Semantic Scholar
Increased circulating levels of osteoclast precursors in Gaucher disease patients: Implicances for bone pathology
J. Mucci, F. Cuello, I. Kisinovsky, M. Larroudé +3 more
20130 citations
Semantic Scholar
Two-Year Efficacy And Safety Of Velaglucerase Alfa In Patients With Type 1 Gaucher Disease Switching From Imiglucerase: Phase III Trial HGT-GCB-039 And Extension
E. Crombez, P. Kishnani, H. Ben Turkia, D. González +8 more
20120 citations
Semantic Scholar
Two-Year Safety and Tolerability of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease, Including Patients Switched From Imiglucerase: Phase III Trial HGT-GCB-039 and Extension,
A. Mehta, H. Ben Turkia, D. González, M. Kabra +13 more
20110 citations
Semantic Scholar
Peripheral neuropathy and VIII cranial nerve involvement in Fabry disease
R. Reisin, C. Marchesoni, S. Carmona, A. Pardal +6 more
20100 citations
Semantic Scholar
Velaglucerase Alfa (VPRIV) Enzyme Replacement Therapy in Velaglucerase Alfa (VPRIV) Enzyme Replacement Therapy in Patients with Gaucher Disease: Long-Term Data from Phase III Patients with Gaucher Disease: Long-Term Data from Phase III Clinical Trials Clinical Trials
D. Hughes, D. González, E. Lukina, Atul B. Mehta +9 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Reisin×10
Invite
R. Reisin — researcher profile on SciRah
P. Rozenfeld×10
Invite
P. Rozenfeld — researcher profile on SciRah
G. Cáceres×9
Invite
G. Cáceres — researcher profile on SciRah
D. González×8
Invite
D. González — researcher profile on SciRah

×8

Invite

E. Crombez — researcher profile on SciRah

Invite

A. Zimran — researcher profile on SciRah

Invite

E. Lukina — researcher profile on SciRah

M. Ben Dridi×6

Invite

M. Ben Dridi — researcher profile on SciRah

C. Marchesoni×6

Invite

C. Marchesoni — researcher profile on SciRah

Pablo Neumann×6

Invite

Pablo Neumann — researcher profile on SciRah

Invite

M. Kabra — researcher profile on SciRah

Invite

A. Bavdekar — researcher profile on SciRah